Insulin Replacement Therapy for Type 2 Diabetes
Patient-Centered Management of Hyperglycemia in Primary Care
Meeting Slides
Suggested Readings
American Diabetes Association: Standards of Medical Care in Diabetes—2012.
American Diabetes Association. Diabetes Care. 2012;35(suppl 1):S11-S63.
Adiposity, age, and family history as a simplified prediction of future diabetes mellitus from the SHIELD study.
Bays H, Fox KM, and Grandy S. Obesity. 2011;19(suppl 1):S223.
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.
Defronzo RA. Diabetes. 2009;58(4):773-795.
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.
Handelsman Y, Mechanick JI, Blonde L, et al. Endocr Pract. 2011;17(suppl 2):1-53.
10-year follow-up of intensive glucose control in type 2 diabetes.
Holman RR, Paul SK, Bethel MA, et al. N Engl J Med. 2008;359(15):1577-1589.
Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Inzucchi SE, Bergenstal RM, Buse JB, et al. Diabetes Care. 2012;35(6):1364-1379.
Basal insulin and cardiovascular and other outcomes in dysglycemia.
ORIGIN Investigators, Gerstein HC, Bosch J, Dagenais GR, et al. N Engl J Med. 2012;367(4):319-328.
Comparing the efficacy, safety, and utility of intensive insulin algorithms for a primary care practice.
Unger J. Diabetes Ther. 2011;2(1):40-50.
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
Wing RR. Arch Intern Med. 2010;170(17):1566-1575.
Interactive PresentationScientific and Clinical Insights Into Type 2 Diabetes
Derek LeRoith, MD, PhD
Relevant Resources
Mechanism-Based Strategies to Achieve Patient-Centered Care
Integrating GLP-1 Receptor Agonists Into Multimodal Treatment Regimens
Translating Research Into Practice
Translating Reseach Into Practice
Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes
Discussions and Debates Around GLP-1 Receptor Agonists
Evolving Roles of GLP-1 Receptor Agonists
Individualizing Evidence-Based Care
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Best Practices in Diagnosis and Management
New Strategies for Insulin Replacement Therapy
Consensus and Controversies Around Intensifying Noninsulin Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
An Evolving Role for Combinations of Injectable Antihyperglycemic Therapies
Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management
Evolving Roles of GLP-1 Receptor Agonists
Looking Beyond Hemoglobin A1c
What You Need to Know
Mechanistic Insights and Evolving Treatment Options
Implications for PCSK9 Inhibitors in Clinical Practice
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Reducing LDL-C and a Lifetime of Cardiovascular Risk
